A new study examined the case of a 30-year-old man who developed sarcoidosis in the lungs after treatment with infliximab (sold as Remicade, Inflectra) for his Crohn’s disease, a chronic condition affecting the gastrointestinal tract. The case study, titled “Pulmonary Sarcoidosis That Developed During the Treatment of a Patient…
News
African-American women face a higher risk than any other ethnic group of developing sarcoidosis, says the American Osteopathic Association (AOA), noting in a new report that the once-rare fibrotic disease now affects an estimated 200,000 Americans. Sarcoidosis, which can be difficult to diagnose because of its varied symptoms, affects one or more…
Anti-TNF agents such as AbbVie’s Humira (adalimumab) or Janssen’s Remicade (infliximab), were found to be effective in treating cutaneous sarcoidosis, according to a French study of 46 cases. The study, “Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis, A French Study…
Sarcoidosis may appear in cancer patients who respond well to treatment with dendritic cell-based vaccines, according to a case series report from Germany. At the Friedrich-Alexander-University Erlangen-Nürnberg and the associated Erlangen University Hospital, researchers noted three patients with malignant melanoma who developed sarcoidosis after or during such treatment.
A rare case report of a woman with sarcoidosis in the liver and spleen, who developed signs of inflammatory bowel disease (IBD) during recovery, illustrates that sarcoidosis can occur in less than typical ways. The study by researchers at the University of Bari Aldo Moro in Italy, titled “A…
A recent case report supports the theory that inhibiting a molecular pathway called programmed cell death-1 (PD-1) may involve processes that lead to sarcoidosis in some cancer patients. The study, “Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma,” was published in the journal JAAD Case Reports. Sarcoidosis, as well…
Increased levels of a specific type of T-cell in some patients with melanoma might explain the connection between the cancer and sarcoidosis, researchers suggest in a study that explored melanoma patients treated with immunotherapy. The study, “Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and…
The prevalence of sarcoidosis may be associated with the presence of high levels of certain chemical elements in the environment, a new study suggests. More studies are warranted to confirm the possible link to pollution. The study was published in the journal PLoS One in an article titled “Sarcoidosis in an…
Treatment with cibinetide (ARA 290) was shown to promote significant corneal nerve and improve pain and functional capacity in a clinical trial with sarcoidosis patients. The trial was conducted by Araim Pharmaceuticals. Results of the trial were published in the journal Investigative Ophthalmology & Visual Science, in an…
A single mother from the American Midwest with sarcoidosis has started a crowdfunding campaign on the GoFundMe platform to move to a warmer climate to improve her life. The campaign has been described as one of GoFundMe’s most important and life-changing of 2017. Stephanie Jordan of Calumet City, Illinois,…
Recent Posts
- New report highlights unmet needs and treatment burdens in sarcoidosis
- Cardiac sarcoidosis symptoms at diagnosis help predict long-term risk
- Methotrexate is safer second-line sarcoidosis treatment than MMF
- A holiday gift guide for your loved one with sarcoidosis
- FSR gathers global leaders to drive progress in sarcoidosis research
- New genetic clues connect sarcoidosis with lung cancer risk
- When patients and caregivers swap roles, empathy usually follows
- Underdiagnosis of cardiac sarcoidosis leaves people at risk
- Repurposing drugs may improve survival for people with sarcoidosis
- Few with sarcoidosis see lung specialist within a year of diagnosis